Morr 12.5% Solution is a topical solution that contains Minoxidil 12.5%. It is primarily used for the treatment of hair loss and is commonly applied to the scalp to help promote hair regrowth in individuals suffering from androgenetic alopecia (male or female pattern baldness) or other types of hair thinning.

Typically, Morr 12.5% Solution should be applied twice daily – once in the morning and once before bedtime. Consistent use is key for optimal results. Do not exceed the recommended dose.

It usually takes 2 to 4 months to start seeing visible improvements in hair regrowth. However, for the best results, continue using the solution as directed for at least 6 months. Hair regrowth results can vary by individual.

If you have sensitive skin, it's important to test Morr 12.5% Solution on a small patch of skin before applying it to your scalp. If you experience irritation or excessive dryness, reduce the frequency of application or consult your dermatologist.

Yes, Morr 12.5% Solution is suitable for both men and women suffering from hair thinning or hair loss. However, women may want to start with a lower concentration (5%) to see how their skin reacts before moving to a higher concentration.

You may use Morr 12.5% Solution with other hair care products, but it is recommended to wait until the solution has fully dried before applying any additional treatments. If you are using other hair loss treatments, consult your dermatologist for the best course of action.

It is generally not recommended to use Morr 12.5% Solution during pregnancy or breastfeeding, as there is limited safety data on its use in these conditions. Always consult your healthcare provider before using this product if you are pregnant, planning to become pregnant, or breastfeeding.

For continued hair growth, it is recommended to continue using Morr 12.5% Solution even after you see positive results. Stopping the treatment may cause hair loss to resume, as the product works to maintain hair regrowth. Consult your doctor before discontinuing use.